OBGYN & Women’s Health
U.S. COVID-19 Vaccine Trial Enrolls 30,000
THURSDAY, Oct. 22, 2020 (HealthDay News) — The first company to start a phase 3 trial of a COVID-19 vaccine reached its target of enrolling 30,000 participants, CNN reported Thursday. The company, Moderna, said that all 30,000 have received the first shot, and most have received the second. Half of the participants were given the...
CDC Broadens Definition of 'Close Contact' in Tracing COVID-19 Infections
THURSDAY, Oct. 22, 2020 (HealthDay News) — In a move that widens the pool of people considered at risk for COVID-19 infection, U.S. health officials released new guidance on Wednesday that redefines who is considered a “close contact” of an infected individual. The change, issued by the U.S. Centers of Disease Control and Prevention, will...
Flavan-3-ol Intake Appears to Lower Systolic Blood Pressure
THURSDAY, Oct. 22, 2020 (HealthDay News) — Flavan-3-ol intake is associated with lower systolic blood pressure, according to a study published online Oct. 21 in Scientific Reports. Javier I. Ottaviani, Ph.D., from Mars Inc. in McLean, Virginia, and colleagues examined cross-sectional associations between biomarker-estimated flavan-3-ol intake and blood pressure and other cardiovascular disease risk markers...
Algorithm Predicts Death, Hospital Admission From COVID-19
THURSDAY, Oct. 22, 2020 (HealthDay News) — A population-based risk algorithm performs well for predicting death and hospital admission due to COVID-19 in adults, according to a study published online Oct. 20 in The BMJ. Ash K. Clift, M.B.B.S., from Radcliffe Observatory Quarter in Oxford, England, and colleagues conducted a population-based cohort study to derive...
CDC: Number of COVID-19 Deaths May Be Underreported
THURSDAY, Oct. 22, 2020 (HealthDay News) — The number of COVID-19-related deaths may be underestimated, according to research published in the Oct. 20 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Lauren M. Rossen, Ph.D., from the CDC in Atlanta, and colleagues assessed trends and demographic patterns...
Fauci 'Cautiously Optimistic' for COVID-19 Vaccine by Year's End
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Anthony Fauci, M.D., the leading infectious disease expert in the United States, said on Wednesday he is “cautiously optimistic” that a COVID-19 vaccine will be ready by year’s end. Against the backdrop of a pandemic that has claimed more than 220,000 American lives, Fauci noted that the country’s...
New Wave of COVID-19 Infections Taking Hold in America
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — A third surge of COVID-19 cases now has a firm grip on the United States, with an average of 59,000 new infections being reported across the country every day. That tally is the highest since the beginning of August, and the likelihood is high that the country will...
Interval Breast Cancers Tied to Worse Outcomes
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Interval breast cancers (IBCs) account for one-fourth of breast cancers detected in routinely screened women, according to a study published online Sept. 25 in JAMA Network Open. Saroj Niraula, M.D., from the University of Manitoba in Winnipeg, Canada, and colleagues compared tumor characteristics of breast cancers diagnosed within...
Vaccine Attributes Influence Readiness to Accept COVID-19 Shot
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Vaccine-related attributes and political characteristics are associated with preference for choosing a hypothetical COVID-19 vaccine, according to a study published online Oct. 20 in JAMA Network Open. Sarah Kreps, Ph.D., from Cornell University in Ithaca, New York, and colleagues conducted a survey study to estimate willingness to receive...
More Medical News
